Mercieca Karl, Azzopardi Matthew, Vallabh Neeru A, Cristian Cristina, Prokosch Verena, Dubois Vincent, Hemmerdinger Christopher, De Cillà Stefano, Mathews Divya, Mermoud Andre, Grieshaber Matthias C, Mégevand Gordana Sunaric, Anand Nitin, Rabiolo Alessandro
University Hospital Eye Clinic, Bonn.
Faculty of Biology, Medicine and Health School of Health Sciences, University of Manchester.
J Glaucoma. 2025 May 1;34(5):349-357. doi: 10.1097/IJG.0000000000002535. Epub 2025 Jan 16.
Deep sclerectomy (DS) and canaloplasty provide better intraocular pressure (IOP) control than viscocanalostomy. DS required less glaucoma medications but more interventions to reach the target IOP.
To compare real-world outcomes of 3 non-penetrating glaucoma surgery (NPGS) techniques.
Retrospective, cohort study of consecutive patients undergoing canaloplasty (CP), deep sclerectomy (DS), and viscocanalostomy (VC), across 9 European glaucoma units. Four intraocular pressure (IOP) criteria were used to define success at 2-year follow-up: (A) IOP≤21 mmHg and ≥20% reduction; (B) IOP≤18 mmHg and ≥20% reduction; (C) IOP≤15 mmHg and ≥25% reduction; (D) IOP≤12 mmHg and ≥30% reduction. Secondary outcomes included IOP control, BCVA, number of medications over time, risk factors for failure, complications, and post-operative interventions. Success was distinguished as qualified or complete, if reached with or without antiglaucoma medications, respectively.
Six hundred eyes (545 patients) undergoing standalone CP (201 eyes), DS (200 eyes), and VC (199 eyes) were included. Qualified success rates of CP, DS, and VP at 24 months were, respectively: (criterion A) 85.1%, 67.6%, and 64.6%; (criterion B) 85.1%, 66.1%, and 58.6%; (criterion C) 76.6%, 55.5%, and 39.0%; (criterion D) 27.7%, 28.5%, and 22.1%. Success rates were significantly different across the 3 techniques ( P =0.04 or below), except for complete success according to criterion A ( P =0.07). Mean IOP(±SD) reduced from 25.2 (±6.9), 20.5 (±6.7), and 22.7 (±7.2)mmHg preoperatively to 13.1 (±3.1), 12.9 (±4.5), and 14.7 (±4.6)mmHg at postoperative year 2 in the CP, DS, and VC groups, respectively ( P <0.001 between preoperative and postoperative time points for all groups).
All 3 NPGS provide sustained IOP reduction, but DS and CP provide better success rates and IOP control. Success rates were low for the most stringent cutoffs, suggesting that other techniques such as trabeculectomy may be indicated when a very low target IOP is demanded.
与房角切开术相比,深层巩膜切除术(DS)和睫状体成形术能更好地控制眼压(IOP)。DS所需的青光眼药物较少,但需要更多干预措施才能达到目标眼压。
比较3种非穿透性青光眼手术(NPGS)技术的实际效果。
对9个欧洲青光眼治疗中心连续接受睫状体成形术(CP)、深层巩膜切除术(DS)和房角切开术(VC)的患者进行回顾性队列研究。采用4种眼压标准来定义2年随访时的成功:(A)眼压≤21 mmHg且降低≥20%;(B)眼压≤18 mmHg且降低≥20%;(C)眼压≤15 mmHg且降低≥25%;(D)眼压≤12 mmHg且降低≥30%。次要结局包括眼压控制、最佳矫正视力(BCVA)、随时间变化的药物数量、失败的危险因素、并发症和术后干预。如果分别在使用或不使用抗青光眼药物的情况下达到成功,则区分为合格成功或完全成功。
纳入了600只眼(545例患者),分别接受单独的CP(201只眼)、DS(200只眼)和VC(199只眼)。CP、DS和VP在24个月时的合格成功率分别为:(标准A)85.1%、67.6%和64.6%;(标准B)85.1%、66.1%和58.6%;(标准C)76.6%、55.5%和39.0%;(标准D)27.7%、28.5%和22.1%。这3种技术的成功率差异显著(P = 0.04或更低),但根据标准A的完全成功率除外(P = 0.07)。CP、DS和VC组的平均眼压(±标准差)从术前分别为25.2(±6.9)、20.5(±6.7)和22.7(±7.2)mmHg降至术后第2年的13.1(±3.1)、12.9(±4.5)和14.7(±4.6)mmHg(所有组术前和术后时间点之间P < 0.001)。
所有3种NPGS均能持续降低眼压,但DS和CP成功率更高且眼压控制更好。对于最严格的标准,成功率较低,这表明当需要极低的目标眼压时,可能需要采用小梁切除术等其他技术。